South Africa Considers Local Production of HIV Prevention Jab Lenacapavir

South Africa has shortlisted three local manufacturers to potentially produce the six-monthly HIV prevention jab lenacapavir. While local production may delay immediate access, it could reduce Africa's dependence on imported medicines. The country faces the challenge of balancing timely access with building local pharmaceutical capacity.

Originally published by gnews